128 related articles for article (PubMed ID: 21725609)
1. PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.
Lai W; Chen S; Wu H; Guan Y; Liu L; Zeng Y; Zhao H; Jiang J; Chu Z
Oncol Rep; 2011 Oct; 26(4):909-17. PubMed ID: 21725609
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner.
Xu H; Lai W; Zhang Y; Liu L; Luo X; Zeng Y; Wu H; Lan Q; Chu Z
BMC Cancer; 2014 May; 14():330. PubMed ID: 24885636
[TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
4. KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer.
Lai W; Liu L; Zeng Y; Wu H; Xu H; Chen S; Chu Z
Med Oncol; 2013; 30(2):566. PubMed ID: 23572150
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
6. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
[TBL] [Abstract][Full Text] [Related]
7. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
8. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
9. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
10. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells].
Fan Y; Zhang YL; Zheng S
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055
[TBL] [Abstract][Full Text] [Related]
11. [Role of silencing PRL-3 expression by miRNA interference in the growth of gastric cancer].
Cai SR; Wang Z; Chen CQ; Cui J; Zhang CH; He YL; Zhan WH
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):618-21. PubMed ID: 18844061
[TBL] [Abstract][Full Text] [Related]
12. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro.
Jäger H; Dreker T; Buck A; Giehl K; Gress T; Grissmer S
Mol Pharmacol; 2004 Mar; 65(3):630-8. PubMed ID: 14978241
[TBL] [Abstract][Full Text] [Related]
13. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.
Wang H; Vardy LA; Tan CP; Loo JM; Guo K; Li J; Lim SG; Zhou J; Chng WJ; Ng SB; Li HX; Zeng Q
Cancer Cell; 2010 Jul; 18(1):52-62. PubMed ID: 20609352
[TBL] [Abstract][Full Text] [Related]
14. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity.
Huang L; Li B; Li W; Guo H; Zou F
Carcinogenesis; 2009 May; 30(5):737-44. PubMed ID: 19176641
[TBL] [Abstract][Full Text] [Related]
15. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.
Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM
Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788
[TBL] [Abstract][Full Text] [Related]
16. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
17. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
[TBL] [Abstract][Full Text] [Related]
18. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
[TBL] [Abstract][Full Text] [Related]
19. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
Wang ZH; Shen B; Yao HL; Jia YC; Ren J; Feng YJ; Wang YZ
Oncogene; 2007 Aug; 26(35):5107-14. PubMed ID: 17310992
[TBL] [Abstract][Full Text] [Related]
20. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
